143 related articles for article (PubMed ID: 3511565)
1. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril.
Hall RL; Wilke WL; Fettman MJ
Toxicol Appl Pharmacol; 1986 Jan; 82(1):164-74. PubMed ID: 3511565
[TBL] [Abstract][Full Text] [Related]
2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
3. Captopril slows the progression of chronic renal disease in partially nephrectomized rats.
Hall RL; Wilke WL; Fettman MJ
Toxicol Appl Pharmacol; 1985 Sep; 80(3):517-26. PubMed ID: 3898470
[TBL] [Abstract][Full Text] [Related]
4. Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
Nakayama K; Hara T; Kusunoki M; Tsutsumi K; Minami A; Okada K; Sakamoto S; Ohnaka M; Miyata T; Nakamura T; Aoki T; Fukatsu A; Nakaya Y; Kakumu S
Metabolism; 2000 May; 49(5):588-93. PubMed ID: 10831167
[TBL] [Abstract][Full Text] [Related]
5. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
6. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
Trachtman H; Del Pizzo R; Valderrama E; Gauthier B
Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316
[TBL] [Abstract][Full Text] [Related]
7. Effect of captopril on the progression of induced pyelonephritis in the rat.
Hall RL; Wilke WL; Fettman MJ
Am J Vet Res; 1986 May; 47(5):1085-8. PubMed ID: 3521405
[TBL] [Abstract][Full Text] [Related]
8. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental nephrotic syndrome with artesunate.
Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
[TBL] [Abstract][Full Text] [Related]
10. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
11. Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy.
Jovanovic D; Dimitrijevic J; Varagic J; Jovovic D; Starcevic A; Djukanovic L
Ren Fail; 1998 May; 20(3):451-8. PubMed ID: 9606733
[TBL] [Abstract][Full Text] [Related]
12. [Protective effects of Chailing Guiqi Decoction combined with lumbrukinase on renal function in rats with adriamycin nephropathy].
Zhang FF; Wang XD; Fan HF; Chen ZQ; Yin ZW; Zhang W
Zhong Xi Yi Jie He Xue Bao; 2005 Jul; 3(4):294-8. PubMed ID: 16009110
[TBL] [Abstract][Full Text] [Related]
13. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy.
Bertani T; Cutillo F; Zoja C; Broggini M; Remuzzi G
Kidney Int; 1986 Oct; 30(4):488-96. PubMed ID: 3784288
[TBL] [Abstract][Full Text] [Related]
14. Progression of chronic adriamycin nephropathy in leukopenic rats.
Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
[TBL] [Abstract][Full Text] [Related]
15. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
[TBL] [Abstract][Full Text] [Related]
16. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
[TBL] [Abstract][Full Text] [Related]
17. Nephrotic syndrome induced by dibasic sodium phosphate injections for twenty-eight days in rats.
Tsuchiya N; Torii M; Narama I; Matsui T
Toxicol Pathol; 2009 Apr; 37(3):270-9. PubMed ID: 19244217
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.
Praga M; Borstein B; Andres A; Arenas J; Oliet A; Montoyo C; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1991 Mar; 17(3):330-8. PubMed ID: 1996578
[TBL] [Abstract][Full Text] [Related]
19. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
